The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Peroxisome Proliferator-Activated Receptors: Vascular and Cardiac Effects in Hypertension
Open accessAbstract
Peroxisome proliferator-activated receptors (PPAR) are nuclear receptors acting as transcription factors on numerous target genes after heterodimerization with the retinoid X receptor. PPAR-α and PPAR-γ may be activated by different agonists, although the endogenous ligands are unknown. Although PPAR-α is mainly involved in fatty acid oxidation and expressed in liver, kidney, and skeletal muscle, and PPAR-γ is mainly involved in fat cell differentiation and insulin sensitivity, both are expressed in smooth muscle cells and myocardium, although PPAR-γ are scarce in the latter. Activators of PPAR-α such as fatty acids and fibrates, and PPAR-γ such as thiazolidinediones have been shown to exert antiproliferative effects, antagonize angiotensin II actions in vivo and in vitro, and exert antioxidant actions inhibiting generation of reactive oxygen species and activation of inflammatory mediators on blood vessels and the heart. These agents lowered blood pressure in several models of hypertension and corrected endothelial dysfunction. They exerted anti-inflammatory and antifibrotic actions on blood vessels and the heart. With the development of dual α/γ-PPAR activators, these newer agents may become interesting therapeutic agents for prevention of vascular and cardiac complications of hypertension as well as for preventative therapy in other forms of cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,086
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Kliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400
Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors
Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G., & Wahli, W. (1992) · Cell · doi:10.1016/0092-8674(92)90031-7 · Cited by 1,376
Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
Staels, B., Koenig, W., Habib, A., Merval, R., Lebret, M., Torra, I. P., Delerive, P., Fadel, A., Chinetti, G., Fruchart, J.-C., et al. (1998) · Nature · doi:10.1038/31701 · Cited by 1,134
Delerive, P., De Bosscher, K., Besnard, S., Vanden Berghe, W., Peters, J. M., Gonzalez, F. J., Fruchart, J.-C., Tedgui, A., Haegeman, G., & Staels, B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32048 · Cited by 1,089
Chinetti, G., Griglio, S., Antonucci, M., Torra, I. P., Delerive, P., Majd, Z., Fruchart, J.-C., Chapman, J., Najib, J., & Staels, B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25573 · Cited by 903
Tugwood, J. D., Issemann, I., Anderson, R. G., Bundell, K. R., McPheat, W. L., & Green, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05072.x · Cited by 895
Peroxisome proliferator-activated receptors in inflammation control
Delerive, P., Fruchart, J., & Staels, B. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1690453 · Cited by 755
Aitman, T. J., Glazier, A. M., Wallace, C. A., Cooper, L. D., Norsworthy, P. J., Wahid, F. N., Al-Majali, K. M., Trembling, P. M., Mann, C. J., Shoulders, C. C., et al. (1999) · Nature Genetics · doi:10.1038/5013 · Cited by 735
Ricote, M., Huang, J., Fajas, L., Li, A., Welch, J., Najib, J., Witztum, J. L., Auwerx, J., Palinski, W., & Glass, C. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7614 · Cited by 721
Marx, N., Sukhova, G. K., Collins, T., Libby, P., & Plutzky, J. (1999) · Circulation · doi:10.1161/01.cir.99.24.3125 · Cited by 599
Poynter, M. E., & Daynes, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32833 · Cited by 550
Pasceri, V., Wu, H. D., Willerson, J. T., & Yeh, E. T. H. (2000) · Circulation · doi:10.1161/01.cir.101.3.235 · Cited by 504
Deactivation of peroxisome proliferator–activated receptor-α during cardiac hypertrophic growth
Barger, P. M., Brandt, J. M., Leone, T. C., Weinheimer, C. J., & Kelly, D. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9056 · Cited by 464
Brandt, J. M., Djouadi, F., & Kelly, D. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.23786 · Cited by 456
Expression and Function of PPARγ in Rat and Human Vascular Smooth Muscle Cells
Law, R. E., Goetze, S., Xi, X.-P., Jackson, S., Kawano, Y., Demer, L., Fishbein, M. C., Meehan, W. P., & Hsueh, W. A. (2000) · Circulation · doi:10.1161/01.cir.101.11.1311 · Cited by 442
Gilde, A. J., van der Lee, K. A. J. M., Willemsen, P. H. M., Chinetti, G., van der Leij, F. R., van der Vusse, G. J., Staels, B., & van Bilsen, M. (2003) · Circulation Research · doi:10.1161/01.res.0000060700.55247.7c · Cited by 399
Peroxisome proliferator‐activated receptors in the cardiovascular system
Bishop‐Bailey, D. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703149 · Cited by 363
IJpenberg, A., Jeannin, E., Wahli, W., & Desvergne, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.20108 · Cited by 352
Diep, Q. N., El Mabrouk, M., Cohn, J. S., Endemann, D., Amiri, F., Virdis, A., Neves, M. F., & Schiffrin, E. L. (2002) · Circulation · doi:10.1161/01.cir.0000016049.86468.23 · Cited by 345
Self-citationPurcell, N. H., Tang, G., Yu, C., Mercurio, F., DiDonato, J. A., & Lin, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111155798 · Cited by 323
Watanabe, K., Fujii, H., Takahashi, T., Kodama, M., Aizawa, Y., Ohta, Y., Ono, T., Hasegawa, G., Naito, M., Nakajima, T., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000248200 · Cited by 314
PPARδ is a very low-density lipoprotein sensor in macrophages
Chawla, A., Lee, C.-H., Barak, Y., He, W., Rosenfeld, J., Liao, D., Han, J., Kang, H., & Evans, R. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337331100 · Cited by 305
Ricote, M., Huang, J. T., Welch, J. S., & Glass, C. K. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.5.733 · Cited by 304
Yue, T.-L., Chen, J., Bao, W., Narayanan, P. K., Bril, A., Jiang, W., Lysko, P. G., Gu, J.-L., Boyce, R., Zimmerman, D. M., et al. (2001) · Circulation · doi:10.1161/hc4601.099403 · Cited by 295
Asakawa, M., Takano, H., Nagai, T., Uozumi, H., Hasegawa, H., Kubota, N., Saito, T., Masuda, Y., Kadowaki, T., & Komuro, I. (2002) · Circulation · doi:10.1161/hc1002.105225 · Cited by 255
PPARα Activator Effects on Ang II–Induced Vascular Oxidative Stress and Inflammation
Diep, Q. N., Amiri, F., Touyz, R. M., Cohn, J. S., Endemann, D., Neves, M. F., & Schiffrin, E. L. (2002) · Hypertension · doi:10.1161/01.hyp.0000037969.41360.cc · Cited by 236
Self-citationInoue, I., Shino, K., Noji, S., Awata, T., & Katayama, S. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8622 · Cited by 199
Yamamoto, K., Ohki, R., Lee, R. T., Ikeda, U., & Shimada, K. (2001) · Circulation · doi:10.1161/hc4001.097186 · Cited by 194
PPARγ and Atherosclerosis: Effects on Cell Growth and Movement
Hsueh, W. A., & Law, R. E. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1201.100261 · Cited by 191
Iglarz, M., Touyz, R. M., Amiri, F., Lavoie, M.-F., Diep, Q. N., & Schiffrin, E. L. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000047447.67827.cd · Cited by 183
Self-citationSatoh, H., Tsukamoto, K., Hashimoto, Y., Hashimoto, N., Togo, M., Hara, M., Maekawa, H., Isoo, N., Kimura, S., & Watanabe, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.0126 · Cited by 182
Takano, H., Nagai, T., Asakawa, M., Toyozaki, T., Oka, T., Komuro, I., Saito, T., & Masuda, Y. (2000) · Circulation Research · doi:10.1161/01.res.87.7.596 · Cited by 181
Diep, Q. N., Touyz, R. M., & Schiffrin, E. L. (2000) · Hypertension · doi:10.1161/01.hyp.36.5.851 · Cited by 173
Self-citationSidell, R. J., Cole, M. A., Draper, N. J., Desrois, M., Buckingham, R. E., & Clarke, K. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1110 · Cited by 165
Llopis, J., Westin, S. K., Ricote, M., Wang, J., Cho, C. Y., Kurokawa, R., Mullen, T.-M., Rose, D. W., Rosenfeld, M. G., Tsien, R. Y., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4363 · Cited by 159
Madej, A., Okopień, B., Kowalski, J., Zieliński, M., Wysocki, J., Szyguła, B., Kalina, Z., & Herman, Z. S. (1998) · PubMed · Cited by 153
Takata, Y., Kitami, Y., Yang, Z., Nakamura, M., Okura, T., & Hiwada, K. (2002) · Circulation Research · doi:10.1161/01.res.0000031271.20771.4f · Cited by 135
Djouadi, F., Brandt, J. M., Weinheimer, C. J., Leone, T. C., Gonzalez, F. J., & Kelly, D. P. (1999) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(99)80009-x · Cited by 133
Ogata, T., Miyauchi, T., Sakai, S., Irukayama‐Tomobe, Y., Goto, K., & Yamaguchi, I. (2002) · Clinical Science · doi:10.1042/cs103s284s · Cited by 126
Glitazones and Heart Failure: Critical Appraisal for the Clinician
Wang, C., Weisel, R. D., Liu, P. P., Fedak, P. W. M., & Verma, S. (2003) · Circulation · doi:10.1161/01.cir.0000054675.30348.9a · Cited by 94
Troglitazone Improves Recovery of Left Ventricular Function After Regional Ischemia in Pigs
Zhu, P., Li, L., Xu, Y., & Schwartz, G. G. (2000) · Circulation · doi:10.1161/01.cir.101.10.1165 · Cited by 91
Diep, Q. N., & Schiffrin, E. L. (2001) · Hypertension · doi:10.1161/01.hyp.38.2.249 · Cited by 80
Self-citationPPARs of the Heart: Three Is a Crowd
Kelly, D. P. (2003) · Circulation Research · doi:10.1161/01.res.0000064382.46274.95 · Cited by 70
Tsuji, T., Mizushige, K., Noma, T., Murakami, K., Ohmori, K., Miyatake, A., & Kohno, M. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200112000-00008 · Cited by 70
Józkowicz, A., Dulak, J., Prager, M., Nanobashvili, J., Nigisch, A., Winter, B., Weigel, G., & Huk, I. (2001) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(01)00155-1 · Cited by 60
Rosiglitazone (Avandia) and pioglitazone (Actos) and heart failure.
Wooltorton, E. (2002) · PubMed Central · Cited by 50
Endothelin-1 Attenuates ω3 Fatty Acid–Induced Apoptosis by Inhibition of Caspase 3
Diep, Q. N., Intengan, H. D., & Schiffrin, E. L. (2000) · Hypertension · doi:10.1161/01.hyp.35.1.287 · Cited by 48
Self-citationMaruyama, S., Kato, K., Kodama, M., Hirono, S., Fuse, K., Nakagawa, O., Nakazawa, M., Miida, T., Yamamoto, T., Watanabe, K., et al. (2002) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.9.87 · Cited by 44
Cited by
Benson, S. C., Pershadsingh, H. A., Ho, C. I., Chittiboyina, A., Desai, P., Pravenec, M., Qi, N., Wang, J., Avery, M. A., & Kurtz, T. W. (2004) · Hypertension · doi:10.1161/01.hyp.0000123072.34629.57 · Cited by 1,073
Cardiac fibroblasts: At the heart of myocardial remodeling
Porter, K. E., & Turner, N. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.05.002 · Cited by 1,010
A PML–PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance
Ito, K., Carracedo, A., Weiss, D., Arai, F., Ala, U., Avigan, D. E., Schafer, Z. T., Evans, R. M., Suda, T., Lee, C.-H., et al. (2012) · Nature Medicine · doi:10.1038/nm.2882 · Cited by 729
Radiation-induced brain injury: A review
Greene-Schloesser, D., Robbins, M. E., Peiffer, A. M., Shaw, E. G., Wheeler, K. T., & Chan, M. D. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00073 · Cited by 700
THE CARDIAC FIBROBLAST: Therapeutic Target in Myocardial Remodeling and Failure
Brown, R. D., Ambler, S. K., Mitchell, M. D., & Long, C. S. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095802 · Cited by 647
Metadata
- Authors
- Schiffrin, E. L., Amiri, F., Benkirane, K., Iglarz, M., & Diep, Q. N.
- Venue
- Hypertension
- Published
- 2003-10
- Volume
- 42
- Issue
- 4
- Pages
- 664-668
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2159719851
- Cited by
- 369
- References
- 54
- FWCI
- 8.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.